Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex : the OPTiMiSE study
BACKGROUND: Negative symptoms are one of the most incapacitating features of Schizophrenia but their pathophysiology remains unclear. They have been linked to alterations in grey matter in several brain regions, but findings have been inconsistent. This may reflect the investigation of relatively small patient samples, and the confounding effects of chronic illness and exposure to antipsychotic medication. We sought to address these issues by investigating concurrently grey matter volumes (GMV) and cortical thickness (CTh) in a large sample of antipsychotic-naïve or minimally treated patients with First-Episode Schizophrenia (FES).
METHODS: T1-weighted structural MRI brain scans were acquired from 180 antipsychotic-naïve or minimally treated patients recruited as part of the OPTiMiSE study. The sample was stratified into subgroups with (N = 88) or without (N = 92) Prominent Negative Symptoms (PMN), based on PANSS ratings at presentation. Regional GMV and CTh in the two groups were compared using Voxel-Based Morphometry (VBM) and FreeSurfer (FS). Between-group differences were corrected for multiple comparisons via Family-Wise Error (FWE) and Monte Carlo z-field simulation respectively at p < 0.05 (2-tailed).
RESULTS: The presence of PMN symptoms was associated with larger left inferior orbitofrontal volume (p = 0.03) and greater CTh in the left lateral orbitofrontal gyrus (p = 0.007), but reduced CTh in the left superior temporal gyrus (p = 0.009).
CONCLUSIONS: The findings highlight the role of orbitofrontal and temporal cortices in the pathogenesis of negative symptoms of Schizophrenia. As they were evident in generally untreated FEP patients, the results are unlikely to be related to effects of previous treatment or illness chronicity.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Psychological medicine - 53(2023), 8 vom: 28. Juni, Seite 3471-3479 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Demjaha, Arsime [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antipsychotic Agents |
|---|
| Anmerkungen: |
Date Completed 19.06.2023 Date Revised 21.06.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1017/S0033291722000010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337287864 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337287864 | ||
| 003 | DE-627 | ||
| 005 | 20231225234056.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S0033291722000010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1124.xml |
| 035 | |a (DE-627)NLM337287864 | ||
| 035 | |a (NLM)35197142 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Demjaha, Arsime |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex |b the OPTiMiSE study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.06.2023 | ||
| 500 | |a Date Revised 21.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Negative symptoms are one of the most incapacitating features of Schizophrenia but their pathophysiology remains unclear. They have been linked to alterations in grey matter in several brain regions, but findings have been inconsistent. This may reflect the investigation of relatively small patient samples, and the confounding effects of chronic illness and exposure to antipsychotic medication. We sought to address these issues by investigating concurrently grey matter volumes (GMV) and cortical thickness (CTh) in a large sample of antipsychotic-naïve or minimally treated patients with First-Episode Schizophrenia (FES) | ||
| 520 | |a METHODS: T1-weighted structural MRI brain scans were acquired from 180 antipsychotic-naïve or minimally treated patients recruited as part of the OPTiMiSE study. The sample was stratified into subgroups with (N = 88) or without (N = 92) Prominent Negative Symptoms (PMN), based on PANSS ratings at presentation. Regional GMV and CTh in the two groups were compared using Voxel-Based Morphometry (VBM) and FreeSurfer (FS). Between-group differences were corrected for multiple comparisons via Family-Wise Error (FWE) and Monte Carlo z-field simulation respectively at p < 0.05 (2-tailed) | ||
| 520 | |a RESULTS: The presence of PMN symptoms was associated with larger left inferior orbitofrontal volume (p = 0.03) and greater CTh in the left lateral orbitofrontal gyrus (p = 0.007), but reduced CTh in the left superior temporal gyrus (p = 0.009) | ||
| 520 | |a CONCLUSIONS: The findings highlight the role of orbitofrontal and temporal cortices in the pathogenesis of negative symptoms of Schizophrenia. As they were evident in generally untreated FEP patients, the results are unlikely to be related to effects of previous treatment or illness chronicity | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cortical thickness | |
| 650 | 4 | |a FreeSurfer | |
| 650 | 4 | |a first-episode psychosis | |
| 650 | 4 | |a negative symptoms | |
| 650 | 4 | |a voxel-based morphometry | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 700 | 1 | |a Galderisi, Silvana |e verfasserin |4 aut | |
| 700 | 1 | |a Glenthøj, Birthe |e verfasserin |4 aut | |
| 700 | 1 | |a Arango, Celso |e verfasserin |4 aut | |
| 700 | 1 | |a Mucci, Armida |e verfasserin |4 aut | |
| 700 | 1 | |a Lawrence, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a O'Daly, Owen |e verfasserin |4 aut | |
| 700 | 1 | |a Kempton, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Ciufolini, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Baandrup, Lone |e verfasserin |4 aut | |
| 700 | 1 | |a Ebdrup, Bjørn H |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez-Jimenez, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Diaz-Marsa, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Díaz-Caneja, Covadonga Martinez |e verfasserin |4 aut | |
| 700 | 1 | |a Winter van Rossum, Inge |e verfasserin |4 aut | |
| 700 | 1 | |a Kahn, Rene |e verfasserin |4 aut | |
| 700 | 1 | |a Dazzan, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a McGuire, Philip |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Psychological medicine |d 1970 |g 53(2023), 8 vom: 28. Juni, Seite 3471-3479 |w (DE-627)NLM000076112 |x 1469-8978 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2023 |g number:8 |g day:28 |g month:06 |g pages:3471-3479 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/S0033291722000010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2023 |e 8 |b 28 |c 06 |h 3471-3479 | ||